Economic Evaluation of Vancomycin Therapeutic Drug Monitoring Methods
Status:
Active, not recruiting
Trial end date:
2020-09-01
Target enrollment:
Participant gender:
Summary
Vancomycin is a widely used antibiotic in the treatment of complicated gram positive
infections. Approaches to vancomycin therapeutic drug monitioring (TDM) vary. This clinical
trial aimed to compare the pharmacoeconomic outcomes between various vancomyicn TDM
approaches.
Research questions: Which vancomycin therapeutic drug monitoring (TDM) approach is associated
with superior economic outcomes?
-Objectives: In this proposed multicenter randomized controlled trial (RCT), we aim to
compare the pharmacoeconomic outcomes of various vancomycin TDM approaches.